ArticleCureus2026
Wiskott-Aldrich Syndrome With Severe Thrombocytopenia and Hemorrhagic Manifestations: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency characterized by the association of thrombocytopenia with microplatelets, eczema, and immune dysfunction, with a highly variable clinical presentation that may include severe hemorrhagic and infectious manifestations in early childhood. We report the case of an infant referred for evaluation of a hemorrhagic syndrome associated with eczema, in whom laboratory investigations revealed severe thrombocytopenia. The clinical course was complicated by a cerebral hemorrhage. The patient was managed with supportive measures, including intravenous immunoglobulin therapy and antibiotic prophylaxis. Despite treatment, thrombocytopenia persisted and required repeated platelet transfusions. Immunosuppressive therapy with corticosteroids and ciclosporin was introduced. This case highlights the importance of early recognition of WAS in infants presenting with thrombocytopenia and eczema, and emphasizes that management remains mainly supportive, while early evaluation for hematopoietic stem cell transplantation is essential to improve prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.